Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors.
Smith, A., Ni, Z.J., Poon, D., Huang, Z., Chen, Z., Zhang, Q., Tandeske, L., Merritt, H., Shoemaker, K., Chan, J., Kaufman, S., Huh, K., Murray, J., Appleton, B.A., Cowan-Jacob, S.W., Scheufler, C., Kanazawa, T., Jansen, J.M., Stuart, D., Shafer, C.M.(2017) Bioorg Med Chem Lett 27: 5221-5224
- PubMed: 29107542 
- DOI: https://doi.org/10.1016/j.bmcl.2017.10.047
- Primary Citation of Related Structures:  
5MZ3, 6B8U - PubMed Abstract: 
A series of imidazo[1,2-a]pyridin-6-yl-benzamide analogs was designed as inhibitors of B-RAF V600E . Medicinal chemistry techniques were employed to explore the SAR for this series and improve selectivity versus P38 and VEGFR2.
Organizational Affiliation: 
Novartis Institutes of Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.